close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar237Point43
Implied share price

Buy Undervalued by 36.6%

5% margin of safety What's this?

EV / EBITDA
Use Average
AMGN
Amgen, Inc.
GILD
Gilead Sciences, Inc.
Change
DNA
Genentech, Inc.
Change
SNY
Sanofi SA (ADR)
Change
WPI
Watson Pharmaceuticals, Inc.
Change
16.68 12.21 4.95 17.08 5.09 41.78
All amounts in millions
from last financial year
         
Implied Share Price $237.43 $288.65 $92.82 $138.61 $32.19
Market Cap 130,102 107,921 100,042 98,744 94,398
Net Debt 47 7,450 -3,369 7,330 41,505
Enterprise Value (EV) 130,149 115,371 96,673 56,725 135,903
Revenue 21,662 32,639 13,418 34,861 15,071
EBITDA 10,657 23,287 5,661 11,136 3,252
Percent 49.2 % 71.3 % 42.2 % 31.9 % 21.6 %
EBIT 8,530 22,189 5,069 7,186 -2,742
Percent 39.4 % 68.0 % 37.8 % 20.6 % -18.2 %
Balance Sheet          
Total Assets 71,449 51,716 21,787 102,321 135,583
Total Liabilities 43,366 33,182 6,116 44,272 58,991
Shareholders Equity 28,083 18,534 15,671 58,049 76,591.4

Comments

No comments yet. Login to comment.